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It has recently been proposed that the increased reinforcing properties of cocaine and ecstasy
observed in rats with a genetic deletion of serotonin transporters are the result of a reduction
in the psychostimulant-induced release of serotonin. Here we provide the neurochemical
evidence in favor of this hypothesis and show that changes in synaptic levels of dopamine or
noradrenaline are not very likely to play an important role in the previously reported enhanced
psychostimulant intake of these serotonin transporter knockout rats. The results may very well
explain why human subjects displaying a reduced expression of serotonin transporters have an
increased risk to develop addiction.
& 2014 Elsevier B.V. and ECNP. All rights reserved.o.2014.09.004
CNP. All rights reserved.
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Animal studies have shown that a genetic deletion of serotonin
transporters (SERT) greatly enhances the reinforcing properties
of cocaine (COC) and ecstasy (MDMA), as well as the acquisition
of their intake (Homberg et al., 2008; Oakly et al., 2014). These
studies performed in SERT knockout (KO) rats are in line with
human studies showing that a reduction in SERTactivity predicts
an increased psychostimulant intake (Gerra et al., 2007; Martin-
Santos et al., 2010). Because of the lack of plasmalemmal
Figure 1 Nucleus accumbens monoamine levels before and after cocaine (COC: 10 mg/kg). (a) Increased baseline levels of
extracellular serotonin (5-HT) in the nucleus accumbens shell of SERT KO rats (Student's t-test: nPo0.05). (b) Reduction in the COC-
induced increase of extracellular accumbal serotonin (5-HT) in SERT KO rats (ANOVA: time effect: Po0.05; genotype time effect:
Po0.05, Student's t-test: nPo0.05). (c–f) In spite of a seemingly small difference in basal accumbal dopamine (DA) and
noradrenaline (NA) levels, neither these baseline monoamine levels nor the COC-induced increases of accumbal dopamine (DA)
and noradrenaline (NA) signiﬁcantly differed between SERT KO and SERT WT rats (n.s.=non-signiﬁcant change). (g) Maximum COC-
induced increase of extracellular accumbal serotonin (5-HT) in (SERT KO) rats that lack serotonin transporters (Student's t-test:
nPo0.05). Open symbols (O/□) represent a signiﬁcant increase relative to baseline (one sample t-test vs. 100%). Data are expressed
as mean7s.e.m. (n=5 rats/group).
1851Reduced COC-induced 5-HT, but not DA and NA, release in SERT KO rats
Figure 2 Hippocampus monoamine levels before and after cocaine (COC: 10 mg/kg). (a) Increased baseline levels of extracellular
serotonin (5-HT) in the ventral hippocampus of SERT KO rats (Student's t-test: nPo0.05). (b) Reduction in the COC-induced increase
of extracellular hippocampal serotonin (5-HT) in SERT KO rats (ANOVA: time effect: Po0.05; genotype time effect: Po0.05,
Student's t-test: nPo0.05). (c–f) No signiﬁcant (n.s.) genotype differences in either baseline levels or COC-induced increases of
hippocampal dopamine (DA) and noradrenaline (NA). (g) Maximum COC-induced increase of extracellular hippocampal serotonin
(5-HT) (SERT KO) rats that lack serotonin transporters (Student's t-test: nPo0.05). Open symbols (O/□) represent a signiﬁcant
increase relative to baseline (one sample t-test vs. 100%). Data are expressed as mean7s.e.m. (n=5 rats/group).
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1853Reduced COC-induced 5-HT, but not DA and NA, release in SERT KO ratsserotonin transporters (Homberg et al., 2007), SERT KO animals
are not only marked by increased extracellular levels of
serotonin (Figures 1a and 2a), but also by a reduced amount
of releasable serotonin inside their cells (Kalueff et al., 2010).
Using 5,7-dihydroxytryptamine-(5,7-DHT)-treated rats, it has
elegantly been shown that a sustained increase in the baseline
extracellular central levels of serotonin results in a decreased,
instead of an increased, intake of psychostimulants (Bradbury
et al., 2014). In a recent self-administration study by Oakly
et al. (2014) it was, therefore, proposed that a reduced evoked
release of serotonin underlies the observed increased
reinforcing properties of COC and MDMA in SERT KO rats.
Here we provide the missing neurochemical evidence
in favor of their hypothesis and show that changes in
synaptic levels of dopamine or noradrenaline are not
likely to play an important role in the enhanced psychos-
timulant intake reported in individuals lacking plasma-
lemmal serotonin transporters.
2. Experimental procedures
SERT KO rats (Slc6a41Hubr) were generated by target-selected ENU-
induced mutagenesis (for detailed description, see Homberg et al.
(2007)). Brieﬂy, high-throughput sequencing from mutagenized rats
revealed a functional ENU-induced premature stop codon in exon
3 of the SERT gene of a female Wistar rat. This heterozygous mutant
animal was outcrossed for at least eight generations to a Wistar
background. Homozygous SERT KO rats were generated by crossing
heterozygous SERT KO animals and genotyping was performed at the
age of 21 days (primer sequences can be found in Homberg et al.
(2007)). All rats were individually housed in our standard micro-
dialysis cages (25 25 35 cm3) under controlled experimental
conditions (12/12 h light/dark cycle, 2171 1C, 60% relative humid-
ity, food and water were available ad libitum). Adult male SERT KO
rats and their wild type (WT) counterparts were intraperitoneally
injected with saline (volume: 1 ml/kg) and cocaine (dose: 10 mg/
kg) and the synaptic levels of serotonin, dopamine, and noradrena-
line were measured in the nucleus accumbens shell and the ventral
hippocampus according to previously described microdialysis pro-
cedures (Homberg et al., 2007; Verheij et al., 2008). The nucleus
accumbens and the hippocampus were chosen because they play an
important role in mediating reward (Carlezon and Thomas, 2009;
Devenport et al., 1981). Statistics are described in the ﬁgure
legends. All experiments were in agreement with institutional,
national, and international laws and guidelines for animal care and
welfare.
3. Results
COC is known to increase the extracellular monoamine levels by
blocking plasmalemmal monoamine transporters (Ritz et al.,
1987). As expected, the COC-induced serotonin increase in both
the nucleus accumbens shell and the ventral hippocampus is
smaller in SERT KO than SERT WT rats (Figures 1b and 2b).
Despite suggestions that the variation in psychostimulant intake
between these two rat types is due to (serotonin-induced)
changes in synaptic dopamine or noradrenaline (Nonkes et al.,
2011; Oakly et al., 2014), the observed genotype differences in
the baseline levels of serotonin (Figures 1a and 2a) were not
accompanied by genotype differences in the baseline levels of
the two other monoamines (dopamine: Figures 1c and 2c;
noradrenaline: Figures 1e and 2e). In addition, SERT KO rats and
their WT counterparts were found not to differ in both theelectrically-evoked central release of dopamine and noradrena-
line (Homberg et al., 2007) as well as the COC-induced increase
of the extracellular levels of these two monoamines in either
the nucleus accumbens (Figure 1d and f) or the hippocampus
(Figure 2d and f). Finally, neither the central expression of
plasmalemmal dopamine and noradrenaline transporters, nor
the uptake by these two transporters differs between
SERT KO and SERT WT rats (Homberg et al., 2007). These
data indicate that both the genotype-speciﬁc central
serotonin response to COC (Figures 1b and 2b) and the
previously reported individual differences in the reinfor-
cing effects of this drug (Homberg et al., 2008) are most
likely not due to (COC-induced) changes in dopaminergic
or noradrenergic neurons. Although these individual dif-
ferences in the reinforcing effects between SERT KO and
SERT WT rats have been found after administration of the
same dose of COC that was used in the present study (see
Homberg et al. (2008)), our study does not fully exclude
the possibility that COC-induced individual differences in
central dopamine and noradrenaline levels may poten-
tially contribute to genotype variation in the reinforcing
effects between the two rat types following the admin-
istration of a different dose of the psychostimulant.4. Discussion
Remarkably, COC signiﬁcantly increased the extracellular
levels of serotonin in SERT KO rats (Figures 1g and 2g). The
ﬁnding that COC increases the extracellular levels of serotonin
in rats lacking serotonin transporters may very well be
explained by our previously reported hypothesis that COC,
like MDMA, releases neurotransmitters from storage vesicles
(Verheij and Cools, 2011; Verheij et al., 2008, 2013). The
previously reported ﬁnding that the electrically-evoked
release of central serotonin is smaller in SERT KO than SERT
WT rats (Homberg et al., 2007) indicates that the contribution
of (vesicular) release to the COC-induced extracellular ser-
otonin increase is also smaller in SERT KO than that in SERT WT
rats. Our previous and present data, therefore, underline the
notion of Oakly et al. (2014) that a reduction in the evoked
(vesicular) release of serotonin may have contributed to the
enhanced acquisition of psychostimulant intake observed in
individuals with a genetic deletion of plasmalemmal serotonin
transporters. Given that reduced binding of serotonin to its
receptors in the nucleus accumbens prevents both the reward-
ing effects of cocaine and the behavioral sensitization to this
drug (Filip and Cunningham, 2002; Przegalinski et al., 2002;
Zayara et al., 2011), we hypothesize that a decrease of COC-
induced serotonin release in brain regions other than the
nucleus accumbens (e.g., the hippocampus) mediates the
enhanced cocaine self-administration of SERT KO rats. Addi-
tional studies are under way.Role of the funding
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